These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 462584)
1. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer. Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584 [TBL] [Abstract][Full Text] [Related]
2. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO; Lavin PT; Moertel CG Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [TBL] [Abstract][Full Text] [Related]
3. Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer. Lokich JJ; Skarin AT; Mayer RJ; Frei E Cancer; 1977 Dec; 40(6):2792-6. PubMed ID: 589555 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer. Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316 [No Abstract] [Full Text] [Related]
5. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233 [TBL] [Abstract][Full Text] [Related]
6. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU. Vogl SE; Qazi R; Berenzweig M Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902 [TBL] [Abstract][Full Text] [Related]
8. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Baker LH; Vaitkevicius VK; Gehan E Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013 [TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU. Fischetti MR; Carey RW; Weitzman SA; Kaufman S; Kelley RM; Sohier WD Med Pediatr Oncol; 1978; 4(3):277-8. PubMed ID: 683130 [No Abstract] [Full Text] [Related]
10. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel. Posey LE; Morgan LR Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU]. Fleischer I; Wainstein R; Jovtis S; Colombato LO Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086 [TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion. Kane RC; Cashdollar MR; Bernath AM Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
16. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma. Abdallah AM; Soukop M; Bell G; Calman KC Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430 [No Abstract] [Full Text] [Related]
17. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma]. Togni P; Sessa C; Varini M; Cavalli F Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002 [TBL] [Abstract][Full Text] [Related]
18. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
19. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study. Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204 [TBL] [Abstract][Full Text] [Related]
20. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]